Cost-effectiveness of KRAS, EGFR and ALK testing for therapeutic decision making of advanced stage non-small cell lung cancer (NSCLC): the French IFCT-PREDICT.amm study
Drezet, A., Loubière, S., Wislez, M., Beau-Faller, M., Nanni-Métellus, I., Garcia, S., Chenard, M-P., Ghnassia, J-P., Lacave, R., Antoine, M., Duruisseaux, M., Friard, S., Fabre, E., Daniel, C., MissyVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.11
Date:
October, 2016
File:
PDF, 68 KB
english, 2016